Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;34(3):505-514.
doi: 10.1007/s40520-021-01951-7. Epub 2021 Aug 16.

Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review

Lara Vilar Fernandes  1 , Alexandre Elias Gomes Paiva  2 , Ana Clara Borges Silva  2 , Isabela Coelho de Castro  1   2 , Andrezza Fernanda Santiago  1   2 , Erick P de Oliveira #  3 , Laura Cristina Jardim Porto #  4   5
Affiliations

Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review

Lara Vilar Fernandes et al. Aging Clin Exp Res. 2022 Mar.

Abstract

Background: The European Working Group on Sarcopenia in Older People (EWGSOP) recently updated the definition and diagnostic criteria to assess sarcopenia, which can result in important changes in sarcopenia prevalence in older adults.

Aim: To compare the prevalence of sarcopenia through the diagnostic criteria and definition proposed by the first (EWGSOP1) and recent (EWGSOP2) European consensus in older adults. We also aimed to evaluate which sarcopenia consensus is better associated with unfavorable health outcomes.

Methods: The review followed PRISMA guidelines. Embase, Medline (PubMed), Scopus and Web of Science were searched from 2018 to February 2021. The systematic review protocol was registered at PROSPERO (CRD42020213303). The search, selection, and evaluation processes were done in a duplicate and independent manner.

Results: Of the 298 potentially eligible articles, 9 were included in this review. The prevalence of sarcopenia was 17.7% by EWGSOP1 and 11% by EWGSOP2. Evaluating all the studies, the sarcopenia prevalence ranged from 6.2 to 35.3% for the EWGSOP1, and from 3.2 to 26.3% for the EWGSOP2. Five studies have evaluated the association between the prevalence of sarcopenia (EWGSOP1 versus EWGSOP2) and unfavorable health outcomes, in which three studies showed that EWGSOP1 was better associated with increased risk of hospitalization and/or mortality.

Conclusion: In comparison with EWGSOP1, the prevalence of sarcopenia in older adults decreased when diagnosed according to EWGSOP2. Based on limited evidence, EWGSOP2 seems to be worse for predicting unfavorable outcomes compared with EWGSOP1.

Keywords: Elderly; Muscle mass; Muscle strength; Older people; Physical performance; Skeletal muscle.

PubMed Disclaimer

References

    1. Rosenberg IH (1997) Symposium: sarcopenia: diagnosis and mechanisms sarcopenia: origins and clinical relevance 1. J Nutr 127:990–991 - DOI
    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39:412–423. https://doi.org/10.1093/ageing/afq034 - DOI - PubMed - PMC
    1. Cruz-Jentoft AJ, Bahat GG, Bauer JJ et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169 - DOI - PubMed
    1. Kim H, Hirano H, Edahiro A et al (2016) Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 16:110–122. https://doi.org/10.1111/ggi.12723 - DOI - PubMed
    1. Pagotto V, Silveira EA (2014) Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr 59:288–294. https://doi.org/10.1016/j.archger.2014.05.009 - DOI - PubMed

Publication types

LinkOut - more resources